Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
Aug 26, 2026, 3:00 PM AEST

Cynata Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
33453225272
Market Cap Growth
-94.06%-36.04%136.00%-56.47%-28.71%1.27%
Enterprise Value
0234262547
Last Close Price
0.010.150.290.130.360.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-103.85103.85103.85103.85103.85
PS Ratio
1.5917.9822.8813.576.6446.80
PB Ratio
0.795.677.341.342.152.55
P/TBV Ratio
0.795.677.341.342.152.55

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
0.0512.4118.063.653.1930.68

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Debt / Equity Ratio
-0.76-0.84-0.86-0.97-0.99-0.94
Net Debt / EBITDA Ratio
0.310.540.621.114.113.68
Asset Turnover
0.190.240.170.070.280.07
Quick Ratio
2.364.245.397.309.2316.71
Current Ratio
2.494.405.587.469.3317.03
Return on Equity (ROE)
-112.99%-142.29%-81.37%-70.17%-20.81%-34.05%
Return on Assets (ROA)
-62.05%-77.08%-46.70%-40.86%-13.42%-19.85%
Return on Capital Employed (ROCE)
-254.50%-160.70%-141.70%-89.00%-25.30%-26.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-313.79%-27.71%-18.39%-63.59%-10.56%-10.63%
Buyback Yield / Dilution
-26.09%-14.09%-23.80%-1.27%-9.85%-24.80%